发明名称 |
Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment |
摘要 |
The invention provides compositions and methods for identifying patients for single agent anti-EGFR therapy. The methods comprise determining the genomic polymorphism present in a predetermined region of a gene of interest and correlating the polymorphism to the predictive response. Patients identified as responsive are then treated with the appropriate therapy.
|
申请公布号 |
US2010172901(A1) |
申请公布日期 |
2010.07.08 |
申请号 |
US20080523517 |
申请日期 |
2008.01.17 |
申请人 |
UNIVERSITY OF SOUTHEM CALIFORNIA |
发明人 |
LENZ HEINZ-JOSEF;ZHANG WU |
分类号 |
A61K39/395;A61P1/00;A61P35/00;C12Q1/68 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|